According to Fortune Business Insights, the global prefilled syringes market size was valued at USD 9.59 billion in 2025 and is projected to grow from USD 10.6 billion in 2026 to USD 26.41 billion by 2034, exhibiting a CAGR of 12.1% during the forecast period from 2026 to 2034. Europe dominated the market with a 40.6% share in 2025.
Market Overview
Prefilled syringes provide pharmaceutical manufacturers and healthcare providers with an efficient method of delivering injectable medicines. Their benefits include dose accuracy, ease of use, reduced contamination risk, and suitability for self-administration. These characteristics have increased their application across treatments for rheumatoid arthritis, cancer, diabetes, and other chronic conditions.
The market is also benefiting from the increasing demand for biologics, biosimilars, and vaccines. Pharmaceutical companies are increasingly incorporating injectable drugs into prefilled delivery formats to improve patient convenience and compliance. Growing research and development activities and approvals of biologic products in prefilled syringe formats are expected to further support market growth.
For detailed market insights: https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946
Market Trends
Shift from Glass to Polymeric Materials
One of the notable trends in the market is the increasing interest in polymeric materials such as Cyclo-Olefin-Polymer (COP). These materials offer break resistance, glass-like transparency, low oxygen permeation, chemical stability, and design flexibility. Manufacturers are also investing in the development of more stable resins for advanced syringe applications.
Growing Demand for Homecare Treatment
The shift toward self-injection and home-based treatment is expanding the use of prefilled syringes. Patients managing chronic diseases can benefit from convenient drug administration, while healthcare systems can support treatment outside traditional clinical environments.
Rising Demand for Dual-Chamber Syringes
Dual-chamber syringes are becoming increasingly relevant for lyophilized and combination drugs, particularly across North America and Europe. Their design can support the storage of biological components that may have limited stability over extended periods.
Advanced Product Development
Manufacturers are introducing technologies such as glass-plastic hybrid barrels, smart safety caps, and temperature-resistant materials. These developments are aimed at improving safety, performance, usability, and product sustainability.
Market Drivers
Increasing Demand for Biologics, Biosimilars, and Vaccines
The increasing use of biologics and biosimilars is a major factor supporting demand for prefilled syringes. These systems offer convenience, dose accuracy, and self-administration benefits while helping reduce costs associated with overfilling. Increasing approvals of biologic products in prefilled formats are expected to strengthen demand.
Rising Focus on Needlestick Safety
Needlestick injuries among healthcare professionals remain an important safety concern. Prefilled drug delivery systems can support safer and more controlled administration, contributing to demand for advanced syringe technologies.
Growing Chronic Disease Burden
The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is generating demand for convenient drug delivery systems. According to the source, the global burden of cancer is expected to reach 27.5 million new cases by 2040, while approximately 50 million Americans currently suffer from autoimmune disorders.
However, complex manufacturing processes, product recalls, stringent regulatory requirements, manufacturing capacity gaps, and high costs can limit market expansion.
Market Segmentation
The prefilled syringes market is segmented by material, closing system, product, application, design, end-user, and region.
By Material: The market is divided into glass and plastic. The glass segment is expected to hold a 75.84% share in 2026, supported by its compatibility with biological products and ability to prevent interaction between drug compounds and water vapor and oxygen. The plastic segment is expected to record an 11.5% CAGR during the forecast period.
By Closing System: The segments include staked needle, Luer cone, and Luer lock form systems. The staked needle system is projected to account for a significant share because of simplified administration and fewer opportunities for user error.
By Product: Complete syringe sets and components & accessories constitute the product segments. The complete syringe set segment held an 85.09% share in 2026, driven by demand for effective drug delivery and self-injectable systems.
By Application: The market covers cancer, rheumatoid arthritis, diabetes, and others. Rheumatoid arthritis is projected to lead with a 52.74% share in 2026, while cancer is expected to record the fastest CAGR of 11.7%.
By Design: Single-chamber, double-chamber, and multiple-chamber syringes are covered. The single-chamber segment is projected to hold a 73.2% share, although demand for double-chamber systems is increasing for biologic and lyophilized drugs.
By End User: Pharmaceutical & biotechnology companies, contract research & manufacturing organizations, and others are included. Pharmaceutical & biotechnology companies are expected to hold the largest share at 55.47% in 2026, supported by demand for biologics, vaccines, and biosimilars.
Key Players
Major companies profiled in the market include BD, SCHOTT Pharma, Gerresheimer AG, West Pharmaceutical Services, Inc., Nipro Group Companies, AptarGroup, Inc., Terumo Corporation, and Ypsomed AG.
Regional Analysis
Europe led the global market in 2025 with revenue of USD 3.89 billion, representing 40.6% of global revenue, and is projected to reach USD 4.32 billion in 2026. Strong biologics adoption, self-injection trends, and the presence of major manufacturers support regional growth.
North America generated USD 3.71 billion in 2025 and is projected to reach USD 4.1 billion in 2026. Chronic disease prevalence, self-administration trends, product launches, and strong distribution networks are supporting growth. The U.S. market is projected to reach USD 3.86 billion in 2026.
Asia Pacific generated USD 1.48 billion in 2025 and is projected to reach USD 1.62 billion in 2026. Increasing chronic disease prevalence, a growing patient population, biologics demand, and contract manufacturing activities are supporting regional expansion. China, India, and Japan are important country markets, with Japan projected to reach USD 0.55 billion in 2026.
Latin America and the Middle East & Africa are also expected to expand, with increasing adoption of advanced drug delivery systems contributing to market opportunities.
Competitive Landscape
The competitive landscape is characterized by product development, capacity expansion, partnerships, and technological innovation. BD, Gerresheimer AG, SCHOTT Pharma, and West Pharmaceutical Services accounted for a significant portion of the global market share in 2024.
Recent developments include Gerresheimer's expansion of syringe production capacity in North Macedonia and BD's expansion of its Neopak Glass Prefillable Syringe platform. SCHOTT Pharma also launched polymer syringe technology aimed at improving safety, efficacy, and sustainability. Strategic collaborations are being used by leading companies to strengthen product portfolios and technological capabilities.
Future Outlook
The future of the prefilled syringes market is expected to be shaped by the increasing use of biologics and biosimilars, expansion of home-based treatment, demand for self-injection, and development of technologically advanced syringe systems. Polymer-based products, dual-chamber designs, improved safety features, and innovative materials are likely to remain important areas of development.
At the same time, manufacturers will need to address production capacity, regulatory requirements, product quality, recalls, and cost-related challenges. Continued investments in research and development and strategic partnerships are expected to help companies strengthen their market positions.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prefilled-syringes-market-101946
Conclusion
The global prefilled syringes market is positioned for strong growth as healthcare systems and pharmaceutical manufacturers increasingly prioritize convenient, accurate, and safer injectable drug delivery. Rising chronic disease prevalence, biologics adoption, self-administration, and technological advancements are creating significant opportunities. With the market projected to reach USD 26.41 billion by 2034 at a 12.1% CAGR, innovation in materials, designs, safety technologies, and manufacturing capabilities will remain central to future market development.
Latest 5 Trending FAQs
What is the size of the prefilled syringes market in 2025?
The global prefilled syringes market was valued at USD 9.59 billion in 2025.What will be the prefilled syringes market size by 2034?
The market is projected to reach USD 26.41 billion by 2034, growing from USD 10.6 billion in 2026.What is the CAGR of the prefilled syringes market?
The market is expected to grow at a 12.1% CAGR from 2026 to 2034.Which segment dominates the prefilled syringes market?
By material, glass is expected to be the leading segment, with a projected 75.84% share in 2026. By application, rheumatoid arthritis is projected to lead with a 52.74% share.Which region dominated the prefilled syringes market in 2025?
Europe dominated the global market in 2025, accounting for a 40.6% share.
What’s Driving Japan’s Market? Discover the Latest Prefilled Syringes Market Insights
Top comments (0)